Millennium Pharmacon International (SDPC) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.063x

Based on the latest financial reports, Millennium Pharmacon International (SDPC) has a cash flow conversion efficiency ratio of -0.063x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp-18.67 Billion ≈ $-1.09 Million USD) by net assets (Rp296.69 Billion ≈ $17.39 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see SDPC market cap for the company's overall valuation and market capitalisation.

Millennium Pharmacon International - Cash Flow Conversion Efficiency Trend (2004–2024)

This chart illustrates how Millennium Pharmacon International's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Millennium Pharmacon International Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Millennium Pharmacon International ranked by their cash flow conversion efficiency. Explore SDPC cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Silverline Endustri ve Ticaret AS IS:SILVR	-0.012x
Anugerah Kagum Karya Utama Tbk PT JK:AKKU	0.000x
Donegal Investment Group PLC IR:DQ7A	-0.234x
FACILITIES BY ADF LS-01 F:ZC8	N/A
MDB Capital Holdings, LLC Class A common NASDAQ:MDBH	-0.052x
Regentis Biomaterials Ltd. NYSE:RGNT	N/A
YXT.COM GROUP HOLDING LIMITED American Depository Shares NASDAQ:YXT	-0.280x
Pharma Equity Group A/S Cl A CO:PEG	-0.261x

Annual Cash Flow Conversion Efficiency for Millennium Pharmacon International (2004–2024)

The table below shows the annual cash flow conversion efficiency of Millennium Pharmacon International from 2004 to 2024. View latest Millennium Pharmacon International stock price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Rp282.50 Billion ≈ $16.55 Million	Rp-125.45 Billion ≈ $-7.35 Million	-0.444x	-34.56%
2023-12-31	Rp277.71 Billion ≈ $16.27 Million	Rp-91.65 Billion ≈ $-5.37 Million	-0.330x	-308.43%
2022-12-31	Rp258.91 Billion ≈ $15.17 Million	Rp41.00 Billion ≈ $2.40 Million	0.158x	+306.44%
2021-12-31	Rp236.98 Billion ≈ $13.89 Million	Rp-18.18 Billion ≈ $-1.07 Million	-0.077x	-124.52%
2020-12-31	Rp229.20 Billion ≈ $13.43 Million	Rp71.69 Billion ≈ $4.20 Million	0.313x	+391.54%
2019-12-31	Rp235.44 Billion ≈ $13.80 Million	Rp-25.26 Billion ≈ $-1.48 Million	-0.107x	-627.27%
2018-12-31	Rp232.11 Billion ≈ $13.60 Million	Rp4.72 Billion ≈ $276.75K	0.020x	-2.94%
2017-12-31	Rp212.61 Billion ≈ $12.46 Million	Rp4.46 Billion ≈ $261.18K	0.021x	+111.13%
2016-12-31	Rp143.28 Billion ≈ $8.40 Million	Rp-26.99 Billion ≈ $-1.58 Million	-0.188x	+63.20%
2015-12-31	Rp134.31 Billion ≈ $7.87 Million	Rp-68.74 Billion ≈ $-4.03 Million	-0.512x	-1218.86%
2014-12-31	Rp121.79 Billion ≈ $7.14 Million	Rp-4.73 Billion ≈ $-276.93K	-0.039x	+91.69%
2013-12-31	Rp114.87 Billion ≈ $6.73 Million	Rp-53.67 Billion ≈ $-3.14 Million	-0.467x	-2326.94%
2012-12-31	Rp104.62 Billion ≈ $6.13 Million	Rp2.19 Billion ≈ $128.61K	0.021x	+118.58%
2011-12-31	Rp94.78 Billion ≈ $5.55 Million	Rp-10.70 Billion ≈ $-626.92K	-0.113x	-273.40%
2007-12-31	Rp70.24 Billion ≈ $4.12 Million	Rp4.57 Billion ≈ $267.94K	0.065x	+391.77%
2006-12-31	Rp60.63 Billion ≈ $3.55 Million	Rp802.62 Million ≈ $47.03K	0.013x	-78.04%
2004-12-31	Rp45.18 Billion ≈ $2.65 Million	Rp2.72 Billion ≈ $159.57K	0.060x	--

About Millennium Pharmacon International

JK:SDPC Indonesia Medical Distribution

Market Cap

$14.33 Million

Rp244.61 Billion IDR

Market Cap Rank

#26202 Global

#580 in Indonesia

Share Price

Rp192.00

Change (1 day)

-0.52%

52-Week Range

Rp134.00 - Rp208.00

All Time High

Rp357.65